TITLE

PSA mass screening: is there enough evidence?

AUTHOR(S)
Rocco, Bernardo; Grasso, Angelica; Sosnowski, Roman; dell'Orto, Paolo Guido; Albo, Giancarlo; Castle, Erik; Coelho, Rafael; Patel, Vip; Mottrie, Alex
PUB. DATE
March 2012
SOURCE
Central European Journal of Urology;2012, Vol. 65 Issue 1, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Prostate cancer plays an important role in widely understood aspects of men's health, and is becoming a growing problem in terms of public life. Prostate cancer is one of the most common neoplasms among men. Male patients can live with prostate cancer for a long time so it is important to offer appropriate males adequate diagnostic tools and treatments. Prostate cancer and PSA potentially represent a "pair" of a disease and an appropriate indicator to be used in mass screening, but regardless of that there is still active debate about it. Extensive use of PSA screening has modified epidemiology of the diseases. Randomized controlled studies provided sufficient results regarding a reduction in mortality through PSA mass screening, while all agreed on risks of overdiagnosis and overtreatment. New and accurate screening tools are necessary, along with adequate counseling and risk stratification.
ACCESSION #
87654453

 

Related Articles

  • Information Over Exaggeration. Brawley, Otis W. // U.S. News & World Report;Dec2009, Vol. 146 Issue 11, p24 

    The author argues that informed decision making should be used to decide whether or not a man should undergo prostate specific antigen (PSA) testing to detect prostate cancer. He suggests that there is insufficient clinical evidence to support the claim that PSA testing saves men's lives. He...

  • Treatment of localized prostate cancer. Burchardt, Martin; Huland, Hartwig // World Journal of Urology;Feb2007, Vol. 25 Issue 1, p1 

    The authors reflect on the treatment of localized prostate cancer. They express that with prevalent use of prostate-specific antigen (PSA) for detection of prostate cancer, better chance of cure has been given and possibility of overtreatment has evolved. They point out that PSA has lacked of...

  • Controversies in managing localized prostate cancer: introduction. Arai, Yoichi // International Journal of Clinical Oncology;Oct2014, Vol. 19 Issue 5, p780 

    No abstract available.

  • The confusion surrounding prostate cancer screening faced by family physicians. Hoag, Nathan A.; So, Alan I. // Canadian Urological Association Journal;Jun2012, Vol. 6 Issue 3, p194 

    The author discusses the guidelines for primary care physicians in prostate cancer screening. He mentions that the lack of uniformity and the limitations of prostate-specific antigen as a screening tool have affected the standardized and widely adopted guidelines. He further informs that...

  • Recommendations on screening for prostate cancer with the prostate-specific antigen test.  // CMAJ: Canadian Medical Association Journal;11/4/2014, Vol. 186 Issue 16, p1225 

    The article discusses a guideline released by the Canadian Task Force on Preventive Health Care on prostate cancer screening using the prostate-specific antigen (PSA) test. Topics discussed include the benefits of PSA screening, thresholds for PSA, harms associated with PSA screening, importance...

  • Updated results from a long-term study concludes that regular prostate cancer screening cuts the risk of death from prostate cancer.  // MondayMorning;3/19/2012, Vol. 20 Issue 12, p1 

    The article discusses the result of a study which stated that regular prostate cancer screening helps in reducing the risk of death from prostate cancer. It informs that the screening method involves simple blood tests to measure the levels of prostate-specific antigens (PSA). It further informs...

  • Stop a Killer Before It's Too Late. Walsh, Patrick C. // U.S. News & World Report;Dec2009, Vol. 146 Issue 11, p18 

    The author argues that prostate specific antigen (PSA) testing to detect prostate cancer saves men's lives. He cites falling statistics regarding deaths from prostate cancer since the implementation of PSA testing. He discusses their accuracy and evidence from randomized trials in support of his...

  • Common Problems: Screening for Prostate Cancer.  // Mayo Clinic Guide to Self-Care;2005, p141 

    Focuses on the controversy surrounding the screening for prostate cancer. Digital rectal examination; Blood test for prostate-specific antigen; Some physicians' claims that many men will have unnecessary surgery or radiation because of the screening.

  • Screening and Prostate-Cancer Mortality in a Randomized European Study. Schr�der, Fritz H.; Hugosson, Jonas; Roobol, Monique J.; Tammela, Teuvo L.J.; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Lilja, Hans; Zappa, Marco; Denis, Louis J.; Recker, Franz; Berenguer, Antonio; M��tt�nen, Liisa; Bangma, Chris H.; Aus, Gunnar; Villers, Arnauld; Rebillard, Xavier; van der Kwast, Theodorus; Blijenberg, Bert G. // New England Journal of Medicine;3/26/2009, Vol. 360 Issue 13, p1320 

    Background: The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific�antigen (PSA) testing on death rates from prostate cancer. Methods: We identified 182,000 men between the ages of 50 and 74...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics